Sunpointe LLC Acquires 179 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Sunpointe LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 6.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,930 shares of the healthcare conglomerate’s stock after purchasing an additional 179 shares during the quarter. Sunpointe LLC’s holdings in UnitedHealth Group were worth $1,482,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently made changes to their positions in UNH. Parthenon LLC raised its position in UnitedHealth Group by 12.3% in the fourth quarter. Parthenon LLC now owns 546 shares of the healthcare conglomerate’s stock worth $276,000 after acquiring an additional 60 shares during the period. Financial Perspectives Inc raised its holdings in shares of UnitedHealth Group by 7.2% in the 4th quarter. Financial Perspectives Inc now owns 4,459 shares of the healthcare conglomerate’s stock worth $2,256,000 after purchasing an additional 300 shares during the period. Alberta Investment Management Corp grew its holdings in UnitedHealth Group by 211.4% during the fourth quarter. Alberta Investment Management Corp now owns 24,915 shares of the healthcare conglomerate’s stock valued at $12,604,000 after purchasing an additional 16,915 shares during the period. Summit Place Financial Advisors LLC raised its stake in shares of UnitedHealth Group by 5.1% in the fourth quarter. Summit Place Financial Advisors LLC now owns 5,162 shares of the healthcare conglomerate’s stock valued at $2,611,000 after buying an additional 249 shares during the period. Finally, Vista Capital Partners Inc. grew its stake in shares of UnitedHealth Group by 19.3% during the 4th quarter. Vista Capital Partners Inc. now owns 737 shares of the healthcare conglomerate’s stock worth $373,000 after acquiring an additional 119 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. 0.33% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on UNH shares. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. KeyCorp reissued an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Truist Financial cut their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Oppenheimer increased their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Finally, Piper Sandler decreased their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Trading Up 2.0 %

NYSE UNH opened at $510.75 on Thursday. The stock has a 50-day moving average of $520.62 and a 200-day moving average of $561.67. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The firm has a market cap of $470.03 billion, a PE ratio of 32.95, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the business earned $5.83 earnings per share. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.